Alice’s practice spans all areas of intellectual property, and she has been instructed in matters involving patents, SPCs, trade marks, passing off, copyright, design rights, confidential information and a number of contractual disputes, involving parties from an array of industries.

Selected cases:

Patents

Sandoz v Bristol-Myers Squibb (ongoing) – patent revocation actions relating to the anticoagulant drug apixaban (plausibility, lack of technical contribution, AgrEvo obviousness; G2/21 Sumitomo): [2021] EWHC 1123 (Pat); [2022] EWHC 822 (Pat); [2022] EWHC 1279 (Pat); [2023] EWCA Civ 472.

Pfizer, BioNTech v Moderna; Pfizer, BioNTech v CureVac (ongoing) – two patent infringement and revocation actions concerning Pfizer/BioNTech’s COVID-19 mRNA vaccine, Comirnaty.

Eli Lilly v Teva (ongoing) – action concerning quantum of damages owed to Lilly under an agreement with Teva arising from Teva’s at-risk launch of generic pemetrexed in Germany: [2023] EWHC 68 (Ch).

Siemens v GE – patent infringement and revocation action relating to bearings in wind turbines (novelty, obviousness, Regeneron-type insufficiency, prosecution history, infringement, territoriality): [2022] EWHC 490 (Pat); [2022] EWHC 3034 (Pat); [2023] EWHC 254 (Pat).

Sandoz, Accord, Teva & ors v Bayer (ongoing) – patent revocation and infringement actions relating to once daily dosing for the anticoagulant drug rivaroxaban.

Lufthansa v Panasonic, Astronics & Safran (ongoing) – account of profits arising from the finding of infringement of a patent relating to aircraft in-seat power sockets: [2023] EWHC 1043; [2023] EWHC 1136.

NHS England, Wales & NI v Warner-Lambert – damages inquiry arising from cross-undertakings given in the litigation over the second medical use patent for pregabalin: [2021] EWHC 2182 (Ch); [2022] EWHC 189 (Pat); [2022] EWHC 1856 (Ch).

Geofabrics v Fiberweb – damages inquiry and DNI action arising from the finding of infringement of a patent relating to geocomposite railway trackbed liners: [2021] EWHC 1996 (Pat); [2022] EWHC 2363 (Pat).

Illumina v MGI – multiple patents action concerning DNA sequencing technologies (skilled person, obviousness, priority, plausibility, Regeneron-type insufficiency, collocation, doctrine of equivalents): [2019] EWHC 3767 (Pat), [2020] EWHC 730 (Pat), [2021] EWHC 57 (Pat), [2021] EWHC 361 (Pat); [2021] EWCA Civ 1924.

Trade marks, passing off & copyright

NL Holding v Gordon Murray Automotive (ongoing) – acting for the entity behind the Formula 1 driver Niki Lauda in this passing off and copyright infringement dispute arising from the use of the Niki Lauda name and signature on and in relation to sports cars.

AMC v PMG – High Court trade mark infringement, passing off and breach of contract dispute concerning a fashion brand.

Black Sheep Brewery v Conilon – trade mark and passing off dispute relating to alcoholic beverages and premises selling the same.

Glaxo v Glenmark and Celon – trade mark / passing off dispute concerning the 3D shape of inhalers (3D shape marks, validity, infringement, DNIs); settled shortly before trial.

• 2018 – 2019: 12 month pupillage at Three New Square to Miles Copeland, Dominic Hughes, Jeremy Heald, Tom Hinchliffe QC and Stuart Baran
• 2016 – 2018: Outstanding, Bar Professional Training Course; Graduate Diploma in Law – City, University of London
• 2011 – 2016: First Class Hons, MBiochem Molecular and Cellular Biochemistry – University of Oxford
• Inner Temple GDL and BPTC Exhibition Awards, 2016 / 2017
• City Law School Academic Scholar, 2016
• Mary Lunt Prize in Practical Biochemistry, 2016
• St Hugh’s College Final Honour School Prize, 2016

• 2022 – date: editor of IP sections of the White Book
• 2021 – date: member of the Attorney General’s Civil Panel Counsel Junior Juniors Scheme
• 2021 – date: contributing author to Terrell on the Law of Patents

Alice Hart’s privacy notice can be found here.